Quarterly Transactions Made in Xenon Pharmaceuticals Inc. (XENE)
This table provides information about the institutional ownership of Xenon Pharmaceuticals Inc. (XENE). The information is specifically focused on institutions that hold shares of Xenon Pharmaceuticals Inc..
Shares Purchased
Shares Sold
Quarter | Buy | Sell | Net Activity | |||||
---|---|---|---|---|---|---|---|---|
New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
Q3 2021 | 2,731,535 | 2,405,683 | 5,137,218 | 2,105,116 | 2,147,181 | 4,252,297 | 884,921 | |
Q4 2021 | 15,823,400 | 4,128,528 | 19,951,928 | 3,429,264 | 2,507,506 | 5,936,770 | 14,015,158 | |
Q1 2022 | 4,303,146 | 2,638,544 | 6,941,690 | 4,367,182 | 422,663 | 4,789,845 | 2,151,845 | |
Q2 2022 | 9,234,339 | 3,999,346 | 13,233,685 | 4,146,277 | 1,677,445 | 5,823,722 | 7,409,963 | |
Q3 2022 | 5,157,663 | 1,239,954 | 6,397,617 | 4,385,006 | 31,332 | 4,416,338 | 1,981,279 | |
Q4 2022 | 4,820,948 | 3,779,328 | 8,600,276 | 3,136,370 | 0 | 3,136,370 | 5,463,906 | |
Q1 2023 | 2,974,196 | 3,048,034 | 6,022,230 | 4,747,631 | 0 | 4,747,631 | 1,274,599 | |
Q2 2023 | 4,201,947 | 5,145,909 | 9,347,856 | 4,710,028 | 3,612 | 4,713,640 | 4,634,216 | |
Q3 2023 | 5,328,376 | 2,766,976 | 8,095,352 | 5,501,448 | 0 | 5,501,448 | 2,593,904 | |
Q4 2023 | 12,300,642 | 7,624,829 | 19,925,471 | 6,086,452 | 0 | 6,086,452 | 13,839,019 | |
Q1 2024 | 6,279,686 | 5,478,751 | 11,758,437 | 4,109,589 | 0 | 4,109,589 | 7,648,848 | |
Q2 2024 | 5,014,075 | 613,349 | 5,627,424 | 4,822,580 | 0 | 4,822,580 | 804,844 | |
Q3 2024 | 5,404,602 | 1,186,959 | 6,591,561 | 2,256,670 | 0 | 2,256,670 | 4,334,891 |